🟢 Connect Biopharma is trading 6% up in pre-market as U.S. markets advance

Connect Biopharma is trading 5.96% higher at $0.85, with stronger U.S. markets the clearest available context; no source directly attributes the move to them.

• No new company-specific announcement surfaced for November 2; Nasdaq lists November 11 as the next estimated earnings date and September 30 as the latest press release.
• The S&P 500 is up 0.51%, while the Nasdaq Composite is up 0.89%.